Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca’s Farxiga meets primary endpoint in phase III heart failure study
Image: AstraZeneca’s Farxiga has met primary endpoint in phase III heart failure study. Photo: courtesy of AstraZeneca.
Image: AstraZeneca’s Farxiga has met primary endpoint in phase III heart failure study. Photo: courtesy of AstraZeneca.